Rebalix
Logo InvescoInvesco · sheet of 5 September 2026
ETF sheet · official issuer and register data

Invesco EUR AAA CLO UCITS ETF Dist

CLOD · IE000U7LIXH5 · class Dist · EUR · domicile Ireland
Bonds · Corporate EUR · EurozoneactiveSFDR art. 8
Comparison benchmark: J.P. Morgan European Collateralized Loan Obligation AAA-only Index
TER
0.25%+ trans. 0.28%
Fund size
1.1 bn EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Activeactive management
Income
Distributingquarterly
Duration
0.17 yrsshort (≤3 years)
Launch 10 Feb 2025 · costs from the KID as of 14 Aug 2026 · 160 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 14 Aug 2026
Redemption and Dealing of Shares: The Fund's shares are listed on one or more Stock Exchange(s). Investors can buy or sell shares daily through an intermediary directly or on Stock Exchange(s) on which the shares are traded. In exceptional circumstances investors will be permitted to redeem their shares directly from the Umbrella Fund in accordance with the redemption procedures set out in the prospectus, subject to any applicable laws and relevant charges. Investment objective: The investment objective of the Fund is to seek to provide consistent income…

Performance since series start (in euro) — base 100

10 Feb 20251 Sept 2026 · dividends reinvested where declared by the issuer
2026105100105
High 105 (1 Sept 2026) · low 100 (8 Apr 2025) · last 105. Past performance is not indicative of future results.

Returns in euro

1 year+3.6%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+5.2%

Risk · 1 / 3 / 5 years

Volatility (ann.)1.53%1.53%
Max drawdown−0.87%−0.87%
Sharpe-1.16-1.16
Sortino-1.16-1.16
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CLOD · IE000U7LIXH51
RebalixCLOD · IE000U7LIXH5 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication

Fixed income — as declared by the issuer

Issuer page · 2 Sept 2026

Distributions · per share, in EUR

Frequency: quarterly · last 12 months: 0.6116 EUR (3.03% of NAV) · last ex-date 10 Sept 2026
YearPaymentsTotal (EUR)
202630.4746
202530.512

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 160 securities · top-10 weight = 26.5%
Countries (% of fund)
Ireland97.6%Netherlands3.2%United States1.4%Luxembourg0.8%

Listing venues

ESMA register (FIRDS) and official exchange lists
CLOD · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 9 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Prospectus · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/umbr
The live sheet, always up to date
rebalix.com/en/etf/IE000U7LIXH5
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · CLOD · IE000U7LIXH52